Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -43.70% is 143% below its 5-year average of -17.98%, around the middle of its 5-year range (-80.13%–26.45%).
10.98% above its 12-month average of -49.09%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 20.40%.
NET PROFIT MARGIN
-43.70%
NET PROFIT MARGIN AVG TTM
-49.09%
NET PROFIT MARGIN AVG 3Y
-24.12%
NET PROFIT MARGIN AVG 5Y
-17.98%
NET PROFIT MARGIN AVG 10Y
-3.23%
NET PROFIT MARGIN AVG 15Y
-3.35%
NET PROFIT MARGIN AVG 20Y
-1.76%
CURRENT VS TTM AVG
+10.98%
CURRENT VS 3Y AVG
-81.17%
CURRENT VS 5Y AVG
-143.07%
CURRENT VS 10Y AVG
-1251.58%
CURRENT VS 15Y AVG
-1205.34%
CURRENT VS 20Y AVG
-2381.18%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-16707.69%
vs the sector median at left
OraSure Technologies, Inc.
Market Cap
$260.94M
Net Profit Margin
-43.70%
TTM Avg
-49.09%
3Y Avg
-24.12%
5Y Avg
-17.98%
Market Cap
$261.24M
Net Profit Margin
-6388.20%
TTM Avg
0.00%
3Y Avg
-1230.00%
5Y Avg
-820.00%
Market Cap
$262.00M
Net Profit Margin
-10994.73%
TTM Avg
-520.92%
3Y Avg
-360.66%
5Y Avg
-288.77%
Market Cap
$263.97M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-5482.65%
5Y Avg
-3802.53%
Market Cap
$258.88M
Net Profit Margin
-568.80%
TTM Avg
-845.08%
3Y Avg
-422.54%
5Y Avg
-626.87%
Market Cap
$258.73M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$262.31M
Net Profit Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.03M
Net Profit Margin
-28.99%
TTM Avg
-27.18%
3Y Avg
-27.76%
5Y Avg
-23.20%
Market Cap
$257.37M
Net Profit Margin
-249.94%
TTM Avg
-1079.05%
3Y Avg
-1080.63%
5Y Avg
-787.30%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OraSure Technologies, Inc. (OSUR) | $260.94M | -43.70% | -49.09% | -24.12% | -17.98% |
| Palisade Bio, Inc. (PALI)vs › | $261.24M | -6388.20% | 0.00% | -1230.00% | -820.00% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $262.00M | -10994.73% | -520.92% | -360.66% | -288.77% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $263.97M | 0.00% | 0.00% | -5482.65% | -3802.53% |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $258.88M | -568.80% | -845.08% | -422.54% | -626.87% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $258.73M | 0.00% | 0.00% | 0.00% | 0.00% |
| Scribe Therapeutics Inc. (SCTX)vs › | $262.31M | N/A | N/A | N/A | N/A |
| Treace Medical Concepts, Inc. (TMCI)vs › | $264.03M | -28.99% | -27.18% | -27.76% | -23.20% |
| AC Immune S.A. (ACIU)vs › | $257.37M | -249.94% | -1079.05% | -1080.63% | -787.30% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $258.34M | 0.00% | 0.00% | -2265.94% | -2185.44% |
Operating Margin
-59.2%
Net Profit Margin
-43.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 20.40% |
| 2026-03-31 | -80.13% |
| 2025-12-31 | -72.06% |
| 2025-09-30 | -50.63% |
| 2025-06-30 | -63.03% |
| 2025-03-31 | -53.59% |
| 2024-12-31 | -28.83% |
| 2024-09-30 | -11.29% |
| 2024-06-30 | -1.13% |
| 2024-03-31 | -6.62% |
| 2023-12-31 | 26.45% |
| 2023-09-30 | 12.51% |
| 2023-06-30 | -5.61% |
| 2023-03-31 | 17.56% |
| 2022-12-31 | 12.84% |
| 2022-09-30 | 4.80% |
| 2022-06-30 | -23.17% |
| 2022-03-31 | -29.45% |
| 2021-12-31 | -16.35% |
| 2021-09-30 | -27.85% |
| 2021-06-30 | -2.37% |
| 2021-03-31 | 6.44% |
| 2020-12-31 | 2.96% |
| 2020-09-30 | 2.17% |
| 2020-06-30 | -35.87% |
| 2020-03-31 | -23.19% |
| 2019-12-31 | 4.91% |
| 2019-09-30 | 36.34% |
| 2019-06-30 | 11.33% |
| 2019-03-31 | -10.82% |
| 2018-12-31 | 20.50% |
| 2018-09-30 | 17.64% |
| 2018-06-30 | 9.45% |
| 2018-03-31 | -5.05% |
| 2017-12-31 | 14.06% |
| 2017-09-30 | 13.62% |
| 2017-06-30 | 13.51% |
| 2017-03-31 | 38.23% |
| 2016-12-31 | 20.27% |
| 2016-09-30 | 19.35% |
| 2016-06-30 | 12.23% |
| 2016-03-31 | 8.41% |
| 2015-12-31 | 14.25% |
| 2015-09-30 | 4.92% |
| 2015-06-30 | 6.48% |
| 2015-03-31 | 0.42% |
| 2014-12-31 | -9.25% |
| 2014-09-30 | 4.09% |
| 2014-06-30 | 9.58% |
| 2014-03-31 | -23.92% |
| 2013-12-31 | 21.60% |
| 2013-09-30 | -7.67% |
| 2013-06-30 | -21.72% |
| 2013-03-31 | -48.32% |
| 2012-12-31 | -26.49% |
| 2012-09-30 | -11.01% |
| 2012-06-30 | -15.75% |
| 2012-03-31 | -15.53% |
| 2011-12-31 | 0.49% |
| 2011-09-30 | -18.05% |
| 2011-06-30 | -12.79% |
| 2011-03-31 | -14.92% |
| 2010-12-31 | -5.43% |
| 2010-09-30 | 1.44% |
| 2010-06-30 | -2.88% |
| 2010-03-31 | -12.23% |
| 2009-12-31 | -13.57% |
| 2009-09-30 | 8.33% |
| 2009-06-30 | -29.87% |
| 2009-03-31 | -9.38% |
| 2008-12-31 | -170.09% |
| 2008-09-30 | -10.45% |
| 2008-06-30 | -11.84% |
| 2008-03-31 | 11.07% |
| 2007-12-31 | 0.14% |
| 2007-09-30 | 0.02% |
| 2007-06-30 | 4.47% |
| 2007-03-31 | 7.39% |
| 2006-12-31 | 5.78% |
| 2006-09-30 | 12.10% |
| 2006-06-30 | 6.88% |
| 2006-03-31 | 5.91% |
| 2005-12-31 | 114.45% |
| 2005-09-30 | 21.07% |
| 2005-06-30 | 8.28% |
| 2005-03-31 | 9.86% |
| 2004-12-31 | -1.73% |
| 2004-09-30 | -2.07% |
| 2004-06-30 | 1.08% |
| 2004-03-31 | -1.31% |
| 2003-12-31 | 3.66% |
| 2003-09-30 | 0.51% |
| 2003-06-30 | -5.51% |
| 2003-03-31 | -12.69% |
| 2002-12-31 | -0.99% |
| 2002-09-30 | -4.77% |
